Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
794.00    4.00 (0.51%)
Bid:
774.00
Ask:
780.00
Spread: 6.00 (0.775%)
Market Cap: £366.00m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Pre-close trading update

1 Dec 2014 07:00

RNS Number : 3904Y
Porvair PLC
01 December 2014
 



For immediate release 1 December 2014

 

 

 

Pre-close trading update

 

Porvair ("Porvair" or "the Group"), the specialist filtration and environmental technologies group, makes the following announcement regarding trading for the year ended 30 November 2014 ahead of its close period.

 

Porvair has continued to trade strongly throughout the year. Both divisions are expected to deliver record results, with revenue for the full year up 24% (28% at constant exchange rates) and earnings marginally ahead of current market expectations.

 

Strong operating cash flow has increased net cash at the year end to around £5m, achieved after capital investments of £5m, mostly spent on expanding manufacturing capacity to meet demand.

 

As anticipated in previous announcements, Group revenue in 2014 received a one-off boost of £20m (2013: £6m) from several large contracts, each of which is proceeding as expected. Profits on these contracts are recognised after making appropriate allowance for the outstanding liabilities, potential risks and warranties. Consequently, we expect further profits to be achieved as milestones are successfully passed over the period to 2017.

 

Revenue in the Microfiltration division was 34% (36% at constant exchange rates) ahead of the prior year. Underlying revenue growth, excluding the impact of the large projects mentioned above, was 9% (11% at constant exchange rates). Aerospace revenue continued to grow steadily and Seal Analytical recorded a record result for the year.

 

Revenue in the Metals Filtration division was 5% (11% at constant exchange rates) ahead of the prior year. Market share gains continued to be made, particularly in iron foundry filtration. The new plant in Wuhan, China, is performing as expected and revenue from aluminium filtration in China was strong.

 

The Group has adopted IAS19 Revised, Employee Benefits, in the year ended 30 November 2014. This increases the defined benefit pension scheme costs charged in the accounts and requires a revision of prior years. Earnings per share for the year ended 30 November 2013, the comparative period, are restated at 12.3 pence compared with the previously reported 12.7 pence.

 

Order books for the start of 2015 are healthy and the Group has a promising pipeline of potential projects.

 

Porvair will announce its preliminary results for the year ended 30 November 2014 on Monday 26 January 2015.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

 

Buchanan Communications

 

0207 466 5000

Charles Ryland / Steph Watson

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration markets, and are derived from its expertise in the design and manufacture of filtration systems using ceramic, metal, plastic and carbon media. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFLZFFLFBK
Date   Source Headline
5th Dec 20197:00 amRNSPre-close trading update
2nd Dec 201911:20 amRNSHolding(s) in Company
2nd Dec 201911:20 amRNSHolding(s) in Company
13th Nov 20192:51 pmRNSHolding(s) in Company
31st Oct 20197:00 amRNSTotal Voting Rights
8th Oct 201910:00 amRNSBlock listing update
20th Sep 201911:38 amRNSDirector/PDMR Shareholding
18th Sep 20197:00 amRNSNine months trading update
5th Sep 20197:00 amRNSAcquisition of Dahlman Industrial Group B.V.
28th Aug 201912:07 pmRNSSecond Price Monitoring Extn
28th Aug 201912:02 pmRNSPrice Monitoring Extension
23rd Aug 201912:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201912:02 pmRNSPrice Monitoring Extension
6th Aug 201912:07 pmRNSSecond Price Monitoring Extn
6th Aug 201912:02 pmRNSPrice Monitoring Extension
28th Jun 201911:30 amRNSDirector/PDMR Shareholding
27th Jun 20194:35 pmRNSPrice Monitoring Extension
24th Jun 20197:00 amRNSHalf Year Results 2019
18th Jun 20197:00 amRNSBoard changes
6th Jun 20197:00 amRNSTrading Update
15th Apr 201912:30 pmRNSHolding(s) in Company
11th Apr 20193:13 pmRNSAGM resolutions
11th Apr 20197:00 amRNSAGM Trading Update
26th Mar 20194:35 pmRNSPrice Monitoring Extension
22nd Mar 201910:59 amRNSHolding(s) in Company
8th Mar 20191:33 pmRNSHolding(s) in Company
12th Feb 201912:02 pmRNSDirector/PDMR Shareholding
28th Jan 20197:00 amRNSResults for the year ended 30 November 2018
24th Dec 201812:40 pmRNSSecond Price Monitoring Extn
24th Dec 201812:35 pmRNSPrice Monitoring Extension
7th Dec 20187:00 amRNSPre-close trading update
21st Sep 20189:57 amRNSDirector/PDMR Shareholding
18th Sep 20187:00 amRNSNine months trading update
7th Sep 20184:40 pmRNSSecond Price Monitoring Extn
7th Sep 20184:35 pmRNSPrice Monitoring Extension
29th Aug 20185:06 pmRNSDirector Declaration
10th Aug 20183:00 pmRNSDirector's Shareholding
10th Jul 20183:22 pmRNSHolding(s) in Company
25th Jun 20187:00 amRNSHalf Yearly Results
6th Jun 20187:00 amRNSTrading Update
1st May 20189:50 amRNSHolding(s) in Company
18th Apr 20184:40 pmRNSSecond Price Monitoring Extn
18th Apr 20184:35 pmRNSPrice Monitoring Extension
17th Apr 20182:21 pmRNSAGM resolutions and Board changes
17th Apr 20187:00 amRNSAGM Trading Update
6th Apr 20184:40 pmRNSSecond Price Monitoring Extn
6th Apr 20184:35 pmRNSPrice Monitoring Extension
19th Mar 20186:16 pmRNSDirector's Shareholding
1st Mar 20187:00 amRNSAcquisition of Keystone Filter
14th Feb 201812:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.